• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症与乳腺癌。调节乳腺肿瘤中巨噬细胞功能的微环境因素:缺氧与血管生成素-2。

Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2.

作者信息

Lewis Claire E, Hughes Russell

机构信息

Tumour Targeting Group, Academic Unit of Pathology, Section of Infection, Inflammation and Immunity, The Sir Henry Wellcome Laboratories for Medical Research, University of Sheffield Medical School, UK.

出版信息

Breast Cancer Res. 2007;9(3):209. doi: 10.1186/bcr1679.

DOI:10.1186/bcr1679
PMID:17601353
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1929095/
Abstract

Considerable evidence has now accumulated for tumour-associated macrophages stimulating key aspects of tumour progression, including the proliferation, survival and metastasis of tumour cells, tumour angiogenesis and suppression of the anti-tumour functions of other immune effectors at the tumour site. Tumour micro-environmental factors such as hypoxia have profound, direct effects on these cells, stimulating many of their pro-tumour functions. Hypoxia also does so indirectly by stimulating the release of the cytokine angiopoietin-2 from tumour cells and tumour blood vessels. This in turn then recruits Tie-2-expressing monocytes into tumours from the bloodstream and inhibits their production of anti-apoptotic and anti-angiogenic cytokines.

摘要

目前已有大量证据表明,肿瘤相关巨噬细胞可刺激肿瘤进展的关键环节,包括肿瘤细胞的增殖、存活和转移、肿瘤血管生成以及抑制肿瘤部位其他免疫效应细胞的抗肿瘤功能。诸如缺氧等肿瘤微环境因素对这些细胞具有深远的直接影响,刺激它们的许多促肿瘤功能。缺氧还通过刺激肿瘤细胞和肿瘤血管释放细胞因子血管生成素-2而间接发挥作用。这反过来又会从血液中招募表达Tie-2的单核细胞进入肿瘤,并抑制它们产生抗凋亡和抗血管生成细胞因子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402c/1929095/cdd09943362a/bcr1679-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402c/1929095/b2b338cda451/bcr1679-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402c/1929095/cdd09943362a/bcr1679-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402c/1929095/b2b338cda451/bcr1679-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/402c/1929095/cdd09943362a/bcr1679-2.jpg

相似文献

1
Inflammation and breast cancer. Microenvironmental factors regulating macrophage function in breast tumours: hypoxia and angiopoietin-2.炎症与乳腺癌。调节乳腺肿瘤中巨噬细胞功能的微环境因素:缺氧与血管生成素-2。
Breast Cancer Res. 2007;9(3):209. doi: 10.1186/bcr1679.
2
Jekyll and Hyde: the role of the microenvironment on the progression of cancer.杰基尔和海德:微环境在癌症进展中的作用。
J Pathol. 2011 Jan;223(2):162-76. doi: 10.1002/path.2803. Epub 2010 Oct 29.
3
The effects of angiopoietin-2 on the growth of tongue carcinoma.血管生成素-2对舌癌生长的影响。
Br J Oral Maxillofac Surg. 2009 Jan;47(1):14-9. doi: 10.1016/j.bjoms.2008.06.008. Epub 2008 Aug 15.
4
Therapeutic potential of cytokine and chemokine antagonists in cancer therapy.细胞因子和趋化因子拮抗剂在癌症治疗中的治疗潜力。
Eur J Cancer. 2006 Apr;42(6):793-802. doi: 10.1016/j.ejca.2006.01.013. Epub 2006 Mar 9.
5
Angiogenesis and inflammation face off.血管生成与炎症对峙。
Nat Med. 2006 Feb;12(2):171-2. doi: 10.1038/nm0206-171.
6
The prognostic role of angiogenesis in breast cancer.血管生成在乳腺癌中的预后作用。
Anticancer Res. 2001 Nov-Dec;21(6B):4325-31.
7
Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.生长激素在血管病理学中的作用:新生血管形成及受体表达与细胞增殖相关。
Anticancer Res. 2007 Nov-Dec;27(6B):4201-18.
8
Macrophages: modulators of breast cancer progression.巨噬细胞:乳腺癌进展的调节因子
Novartis Found Symp. 2004;256:158-68; discussion 168-72, 259-69.
9
Macrophage polarization in tumour progression.肿瘤进展中的巨噬细胞极化
Semin Cancer Biol. 2008 Oct;18(5):349-55. doi: 10.1016/j.semcancer.2008.03.004. Epub 2008 Mar 26.
10
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications.乳腺癌中的淋巴管生成和血管生成特征:形态计量分析及预后意义
Breast Cancer Res Treat. 2009 Jan;113(2):261-73. doi: 10.1007/s10549-008-9936-1. Epub 2008 Feb 22.

引用本文的文献

1
Decrease of Pro-Angiogenic Monocytes Predicts Clinical Response to Anti-Angiogenic Treatment in Patients with Metastatic Renal Cell Carcinoma.促血管生成单核细胞减少预示转移性肾细胞癌患者对抗血管生成治疗的临床反应。
Cells. 2021 Dec 22;11(1):17. doi: 10.3390/cells11010017.
2
Tumor-associated macrophages in osteosarcoma.骨肉瘤中的肿瘤相关巨噬细胞。
J Zhejiang Univ Sci B. 2021 Nov 15;22(11):885-892. doi: 10.1631/jzus.B2100029.
3
S100A gene family: immune-related prognostic biomarkers and therapeutic targets for low-grade glioma.S100A 基因家族:低级别胶质瘤的免疫相关预后生物标志物和治疗靶点。

本文引用的文献

1
Expression of Tie-2 by human monocytes and their responses to angiopoietin-2.人类单核细胞中Tie-2的表达及其对血管生成素-2的反应。
J Immunol. 2007 Jun 1;178(11):7405-11. doi: 10.4049/jimmunol.178.11.7405.
2
Identification of proangiogenic TIE2-expressing monocytes (TEMs) in human peripheral blood and cancer.人外周血和癌症中促血管生成性 Tie2 表达单核细胞(TEMs)的鉴定。
Blood. 2007 Jun 15;109(12):5276-85. doi: 10.1182/blood-2006-10-053504. Epub 2007 Feb 27.
3
Effect of hypoxia on the tumor phenotype: the neuroblastoma and breast cancer models.
Aging (Albany NY). 2021 Jun 8;13(11):15459-15478. doi: 10.18632/aging.203103.
4
Tumor-Associated Neutrophils and Macrophages-Heterogenous but Not Chaotic.肿瘤相关中性粒细胞和巨噬细胞——异质性而非混沌。
Front Immunol. 2020 Dec 2;11:553967. doi: 10.3389/fimmu.2020.553967. eCollection 2020.
5
The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy.肿瘤相关巨噬细胞(TAMs)在肿瘤进展中的作用及靶向治疗的相关进展。
Acta Pharm Sin B. 2020 Nov;10(11):2156-2170. doi: 10.1016/j.apsb.2020.04.004. Epub 2020 Apr 19.
6
MYC as a Multifaceted Regulator of Tumor Microenvironment Leading to Metastasis.MYC 作为肿瘤微环境中转移的多效调节因子
Int J Mol Sci. 2020 Oct 18;21(20):7710. doi: 10.3390/ijms21207710.
7
Metformin's antitumour and anti-angiogenic activities are mediated by skewing macrophage polarization.二甲双胍的抗肿瘤和抗血管生成活性是通过改变巨噬细胞极化来介导的。
J Cell Mol Med. 2018 Aug;22(8):3825-3836. doi: 10.1111/jcmm.13655. Epub 2018 May 4.
8
Association between inflammation and cancer stem cell phenotype in breast cancer.乳腺癌中炎症与癌症干细胞表型之间的关联
Oncol Lett. 2018 Feb;15(2):2380-2386. doi: 10.3892/ol.2017.7607. Epub 2017 Dec 13.
9
S100 Proteins As an Important Regulator of Macrophage Inflammation.S100蛋白作为巨噬细胞炎症的重要调节因子
Front Immunol. 2018 Jan 5;8:1908. doi: 10.3389/fimmu.2017.01908. eCollection 2017.
10
Macrophages: Regulators of the Inflammatory Microenvironment during Mammary Gland Development and Breast Cancer.巨噬细胞:乳腺发育和乳腺癌过程中炎症微环境的调节因子
Mediators Inflamm. 2016;2016:4549676. doi: 10.1155/2016/4549676. Epub 2016 Jan 17.
缺氧对肿瘤表型的影响:神经母细胞瘤和乳腺癌模型
Adv Exp Med Biol. 2006;587:179-93. doi: 10.1007/978-1-4020-5133-3_16.
4
Macrophages regulate the angiogenic switch in a mouse model of breast cancer.巨噬细胞在乳腺癌小鼠模型中调节血管生成开关。
Cancer Res. 2006 Dec 1;66(23):11238-46. doi: 10.1158/0008-5472.CAN-06-1278. Epub 2006 Nov 17.
5
Role of tumor-associated macrophages in tumor progression and invasion.肿瘤相关巨噬细胞在肿瘤进展和侵袭中的作用。
Cancer Metastasis Rev. 2006 Sep;25(3):315-22. doi: 10.1007/s10555-006-9001-7.
6
Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density.血管生成素2在乳腺浸润性导管癌中的表达:其与血管内皮生长因子表达及微血管密度的关系
Breast Cancer Res Treat. 2006 Aug;98(3):261-6. doi: 10.1007/s10549-005-9157-9. Epub 2006 Mar 15.
7
Activation of hypoxia-inducible factor 1 during macrophage differentiation.巨噬细胞分化过程中缺氧诱导因子1的激活。
Am J Physiol Cell Physiol. 2006 Jul;291(1):C104-13. doi: 10.1152/ajpcell.00614.2005. Epub 2006 Feb 15.
8
Distinct role of macrophages in different tumor microenvironments.巨噬细胞在不同肿瘤微环境中的独特作用。
Cancer Res. 2006 Jan 15;66(2):605-12. doi: 10.1158/0008-5472.CAN-05-4005.
9
Macrophages promote angiogenesis in human breast tumour spheroids in vivo.巨噬细胞在体内促进人乳腺肿瘤球体的血管生成。
Br J Cancer. 2006 Jan 16;94(1):101-7. doi: 10.1038/sj.bjc.6602901.
10
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors.Tie2可识别肿瘤血管形成所需的促血管生成单核细胞的造血谱系以及周细胞祖细胞的间充质群体。
Cancer Cell. 2005 Sep;8(3):211-26. doi: 10.1016/j.ccr.2005.08.002.